1. Canada Stocks

  2. •

    Financial Services

  3. •

    Asset Management
Waverunner Capital Inc.

Waverunner Capital Inc.

CHMJF
Waverunner Capital Inc.US flagOther OTC
0.02
USD
- -
- -
114,116.00Market Cap
Waverunner Capital Inc.
CHMJF
(Other OTC)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.38
0.64
- -
- -
- -
- -
- -
Revenue per Share
-3,325.61
-435.95
-178.75
-133.88
-109.29
-56.34
-4.62
-21.13
-8.7
-5.68
-20.23
-21.73
-17.69
-9.66
-3.75
-3.8
-0.78
Basic EPS, GAAP
-2,628.41
-367.91
-165.92
-168.65
-65.01
-0.71
-35.2
-17.2
-7.78
-13.48
-28.68
-13.41
-9.79
-4.86
-2.32
-0.38
-0.06
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-3,623.23
-2,058.81
40.96
21.37
-938.6
-989.15
-552.36
-347.96
-12.2
17.8
3.6
-17.9
-33.68
-34.7
-29.38
-2.58
-0.66
Book Value per Share
307.67
42.19
186.03
98.01
-25.92
1.59
11.57
-0.39
0.43
25.21
17.58
-4.85
-21.11
-21.49
-19.23
-0.25
-0.14
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
5
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,460.47
-1,575.84
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-4
-1
-1
-1
-1
-1
- -
-1
-1
-1
-5
-5
-5
-3
-1
-4
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1,468.23
-3,386.19
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
1
- -
- -
- -
2
8
3
-6
2
-7
- -
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
8
- -
8
- -
- -
- -
LT Debt
- -
- -
1
1
- -
- -
- -
- -
- -
3
4
-1
-5
-6
-7
- -
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-676.34
- -
- -
- -
- -
- -
- -
-296.71
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
- -
- -
1

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
1
Payables & Accruals
- -
- -
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1,339.31%
28.82%
-96.05%
Free Cash Flow
919.36%
-41.73%
-49.55%
Net Income, GAAP
126.21%
23.68%
209.01%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.52
-0.26
-0.75
- -
-3.8
2025
-0.01
- -
-0.03
-0.01
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
MicroSectors -3x Short Artificial Intelligence (AI) ETNs (AIQD)
Ecofin Sustainable and Social Impact Term Fund (TEAF)
Blackstone Loan Financing Limited (BGLF.L)
Fidelity OTC K (FOCKX)
Vanguard U.S. Treasury 0-1 Year Bond UCITS ETF USD (VDST.L)
Franklin International Growth Fund Class R6 (FILRX)
Business
Waverunner Capital Inc. operates as a venture investment enterprise, pursuing opportunistic allocations across a broad spectrum of industries. The firm specializes in providing capital across various stages, including early-stage and seed funding, private investments in public equity, bridge financing, recapitalizations, and growth capital, in addition to secondary investments in limited partner interests. It actively maintains holdings in areas such as renewable energy development, specifically within the wind and solar sectors, a company focused on plant-based wellness products, and ventures in consumer-oriented biotechnology. Waverunner aims to deploy capital across both European and North American markets. It targets equity investments typically ranging from CAD$500,000 to CAD$1 million, with an enterprise value preference between CAD$2 million and CAD$5 million. The company utilizes its own corporate balance sheet and personal capital for these investments. Formerly recognized as Chemistree Technology Inc., the organization rebranded as Waverunner Capital Inc. in June 2024, a change that coincided with an initial share consolidation. Subsequent to this, the company sought shareholder approval in late 2024 for a further share consolidation and, in July 2025, announced a strategic private placement aimed at strengthening its financial position for restructuring and growth initiatives. Established in 2008, Waverunner Capital Inc. maintains its operational headquarters in North Vancouver, Canada.

Company News

APIChatGPT

  • prnewswire.com

    WAVERUNNER TO SEEK SHAREHOLDER APPROVAL FOR SHARE CONSOLIDATION, OTHER MATTERS AT ANNUAL GENERAL AND SPECIAL MEETING

  • newsfilecorp.com

    CSE Bulletin: Name & Symbol Change and Consolidation - Chemistree Technology Inc. (CHM)

  • prnewswire.com

    CHEMISTREE ANNOUNCES NAME CHANGE AND SHARE CONSOLIDATION

  • prnewswire.com

    Chemistree Directors Ratify Debenture Restructuring

  • prnewswire.com

    CHEMISTREE ANNOUNCES RESULTS FROM ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

  • prnewswire.com

    CHEMISTREE DEBENTUREHOLDERS APPROVE DEBT RESTRUCTURING

  • prnewswire.com

    CHEMISTREE TO SEEK DEBENTUREHOLDER APPROVAL FOR DEBT RESTRUCTURING

  • prnewswire.com

    NOTICE - CHEMISTREE CONVERTIBLE DEBENTURE INTEREST PAYMENT

  • prnewswire.com

    Chemistree Investee ImmunoFlex™ Completes Clinical Study and Submits US and International Patent Applications